
Horizon and MIT Solve Announce Second Annual Rare Disease Global Innovation Challenge
Read More
Alnylam becomes a partner in the Medicines Manufacturing Innovation Centre
Read More
Horizon Therapeutics Launches Prize with MIT to Advance Solutions for the Rare Disease Community
Read More
FDA Approves First-of-Its-Kind Implant to Treat Rare Bone Disease as a Humanitarian Use Device
Read More
Study Suggests Genetic Editing Could Correct Rare Disease that Causes Rapid Aging
Read More